Failings of the pharmaceutical industry
Charles Medawar
Abstract
Charles Medawar
Abstract
In this short paper, I shall not emphasize specific failings of the pharmaceutical industry; little would be achieved in trying to do so. Instead, I have premised the arguments in this paper on what I think would be three main points of agreement. The first is that the pharmaceutical industry does have failings; the second is that it is subject to a good deal of criticism, and the third is that the industry does not seem to be able to handle this criticism very well.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In this short paper, I shall not emphasize specific failings of the pharmaceutical industry; little would be achieved in trying to do so. Instead, I have premised the arguments in this paper on what I think would be three main points of agreement. The first is that the pharmaceutical industry does have failings; the second is that it is subject to a good deal of criticism, and the third is that the industry does not seem to be able to handle this criticism very well.
Key concepts: Pharmaceutical industry, Criticism, Subject (documents), Drug industry, Medicine, Engineering ethics, Engineering, Political science